52W $1.00 – $2.90
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.
Revenue breakdown: Adhd Portfolio (87.7%), The Pediatric Portfolio (12.2%), Product And Service Other (0.1%).
Revenue by Segment